A number of intergenic interactions that all include SNPs of SFTPB as well as a single intragenic SFTPA1 and SFTPA2 interaction are likely to be markers for mild and moderate/severe pulmonary disease in CF, respectively. Here, SFTPB is linked to lung disorder.